Even though epitalon isnt widely available as a pharmaceutical-grade prescription, clinicians whove prescribed it in the past have given us valuable insight into how its dosed and administered, as well as the timeline of benefits users can expect to experience
Five decades of research, peer-reviewed clinical data, and 3D imaging studies all point to the same conclusion: this copper peptide produces real, measurable, compounding improvement in skin quality with consistent use
Research has examined its role in: 3-adrenergic receptor upregulation and adipose tissue sensitisation studies Lipolysis stimulation and plasma glycerol elevation in adipocyte models Lipogenesis inhibition and fat accumulation prevention in diet-induced obesity models Fat oxidation and energy expenditure pathway research Metabolic flexibility and substrate oxidation studies in obese murine models Cartilage regeneration and intra-articular joint biology in osteoarthritis models Safety pharmacology genotoxicity, bioavailability, and plasma kinetics profiling Comparative hGH fragment activity studies alongside AOD9401 and native hGH AOD9604 and Adipose Tissue Research In obese Zucker rats treated with oral AOD9604 at 500 g/kg body weight for 19 days, over 50% reduction in body weight gain was observed compared to controls, accompanied by significantly increased lipolytic activity in adipose tissue
Ji DX, Yamashiro LH, Chen KJ, Mukaida N, Kramnik I, Darwin KH, Vance RE
Hall A, Robson CN, Hickson ID, Harris AL, Proctor SJ and Cattan AR
